Apoptosis in human liver carcinoma caused by gold nanoparticles in combination with carvedilol is mediated via modulation of MAPK/Akt/mTOR pathway and EGFR/FAAD proteins.

De Araújo, Raimundo F

Apoptosis in human liver carcinoma caused by gold nanoparticles in combination with carvedilol is mediated via modulation of MAPK/Akt/mTOR pathway and EGFR/FAAD proteins. [electronic resource] - International journal of oncology Jan 2018 - 189-200 p. digital

Publication Type: Journal Article

1791-2423

10.3892/ijo.2017.4179 doi


Antineoplastic Combined Chemotherapy Protocols--pharmacology
Apoptosis--drug effects
Carbazoles--administration & dosage
Carvedilol
ErbB Receptors--metabolism
Gold--administration & dosage
HEK293 Cells
Hep G2 Cells
Humans
Liver Neoplasms--drug therapy
MAP Kinase Signaling System--drug effects
Metal Nanoparticles--administration & dosage
Oxidative Stress--drug effects
Propanolamines--administration & dosage
Proto-Oncogene Proteins c-akt--metabolism
TOR Serine-Threonine Kinases--metabolism